At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1,570 enrolled
Drug / intervention
morphine sulfate extended release capsulesdrug
Likely dose
morphine sulfate extended release capsules 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
AVINZA Control of Chronic Pain, Effectiveness and Safety Study (ACCESS 2008) A Multi-Center Study to Evaluate the Effectiveness and Tolerability of AVINZA for Chronic Moderate-Severe Pain: A Focus on Risk Minimization Assessment, Intervention and Outcomes
In Brief
A Phase 4 clinical trial evaluating morphine sulfate extended release capsules for Pain. Completed, enrolled 1,570 participants across 384 sites in 2 countries.
Detailed Summary
The purpose of this study is to provide information in a broad, "real world" population of chronic pain patients assessing both pain control with AVINZA as well as the potential risk for misuse and abuse.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesPuerto Rico, United States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedMar 2008
Primary CompletionNov 2008
Study CompletionDec 2008
TodayJul 2026
First PostedMar 20, 2008
Enrollment StartMar 1, 2008
Primary CompletionNov 1, 2008
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 18.3 years ago
Interventions
morphine sulfate extended release capsulesdrug
30 mg, 60 mg, 90 mg, 120 mg morphine will be prescribed by the Investigator in accordance with the AVINZA prescribing information.